nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Azoospermia—Procarbazine—brain cancer	0.0749	0.141	CcSEcCtD
Nandrolone decanoate—Oligospermia—Hydroxyurea—brain cancer	0.0745	0.141	CcSEcCtD
Nandrolone decanoate—Azoospermia—Hydroxyurea—brain cancer	0.058	0.109	CcSEcCtD
Nandrolone decanoate—Hoarseness—Procarbazine—brain cancer	0.0459	0.0866	CcSEcCtD
Nandrolone decanoate—MAOB—ganglion—brain cancer	0.0342	0.0815	CbGeAlD
Nandrolone decanoate—MAOA—ganglion—brain cancer	0.0292	0.0695	CbGeAlD
Nandrolone decanoate—MAOB—hindbrain—brain cancer	0.026	0.0618	CbGeAlD
Nandrolone decanoate—Dysphonia—Procarbazine—brain cancer	0.0245	0.0463	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Procarbazine—brain cancer	0.023	0.0433	CcSEcCtD
Nandrolone decanoate—MAOA—hindbrain—brain cancer	0.0221	0.0527	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Procarbazine—brain cancer	0.018	0.0341	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Hydroxyurea—brain cancer	0.0178	0.0335	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Procarbazine—brain cancer	0.0168	0.0316	CcSEcCtD
Nandrolone decanoate—MAOB—brainstem—brain cancer	0.0149	0.0354	CbGeAlD
Nandrolone decanoate—Amenorrhoea—Temozolomide—brain cancer	0.0139	0.0262	CcSEcCtD
Nandrolone decanoate—MAOB—telencephalon—brain cancer	0.0132	0.0314	CbGeAlD
Nandrolone decanoate—MAOA—brainstem—brain cancer	0.0127	0.0302	CbGeAlD
Nandrolone decanoate—AR—telencephalon—brain cancer	0.0124	0.0296	CbGeAlD
Nandrolone decanoate—CYP19A1—gonad—brain cancer	0.0117	0.0279	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Carmustine—brain cancer	0.0113	0.0213	CcSEcCtD
Nandrolone decanoate—MAOA—telencephalon—brain cancer	0.0113	0.0268	CbGeAlD
Nandrolone decanoate—Jaundice—Procarbazine—brain cancer	0.011	0.0208	CcSEcCtD
Nandrolone decanoate—MAOB—pituitary gland—brain cancer	0.0108	0.0256	CbGeAlD
Nandrolone decanoate—MAOB—medulla oblongata—brain cancer	0.0104	0.0247	CbGeAlD
Nandrolone decanoate—AR—gonad—brain cancer	0.0104	0.0247	CbGeAlD
Nandrolone decanoate—AR—pituitary gland—brain cancer	0.0101	0.0241	CbGeAlD
Nandrolone decanoate—MAOB—midbrain—brain cancer	0.00948	0.0226	CbGeAlD
Nandrolone decanoate—MAOB—spinal cord—brain cancer	0.00925	0.022	CbGeAlD
Nandrolone decanoate—MAOA—pituitary gland—brain cancer	0.00917	0.0218	CbGeAlD
Nandrolone decanoate—MAOA—medulla oblongata—brain cancer	0.00885	0.0211	CbGeAlD
Nandrolone decanoate—CYP19A1—endocrine gland—brain cancer	0.00885	0.0211	CbGeAlD
Nandrolone decanoate—CYP19A1—head—brain cancer	0.00874	0.0208	CbGeAlD
Nandrolone decanoate—AR—spinal cord—brain cancer	0.0087	0.0207	CbGeAlD
Nandrolone decanoate—MAOB—endocrine gland—brain cancer	0.00833	0.0198	CbGeAlD
Nandrolone decanoate—MAOB—head—brain cancer	0.00822	0.0196	CbGeAlD
Nandrolone decanoate—MAOA—midbrain—brain cancer	0.00809	0.0193	CbGeAlD
Nandrolone decanoate—CYP19A1—central nervous system—brain cancer	0.00797	0.019	CbGeAlD
Nandrolone decanoate—MAOA—spinal cord—brain cancer	0.00789	0.0188	CbGeAlD
Nandrolone decanoate—AR—endocrine gland—brain cancer	0.00783	0.0186	CbGeAlD
Nandrolone decanoate—AR—head—brain cancer	0.00773	0.0184	CbGeAlD
Nandrolone decanoate—Hypertension—Procarbazine—brain cancer	0.00761	0.0144	CcSEcCtD
Nandrolone decanoate—MAOB—central nervous system—brain cancer	0.00751	0.0179	CbGeAlD
Nandrolone decanoate—MAOB—cerebellum—brain cancer	0.00734	0.0175	CbGeAlD
Nandrolone decanoate—Oedema—Procarbazine—brain cancer	0.0072	0.0136	CcSEcCtD
Nandrolone decanoate—MAOA—endocrine gland—brain cancer	0.00711	0.0169	CbGeAlD
Nandrolone decanoate—AR—central nervous system—brain cancer	0.00706	0.0168	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Temozolomide—brain cancer	0.00705	0.0133	CcSEcCtD
Nandrolone decanoate—MAOA—head—brain cancer	0.00701	0.0167	CbGeAlD
Nandrolone decanoate—Nausea—Lomustine—brain cancer	0.00673	0.0127	CcSEcCtD
Nandrolone decanoate—MAOA—central nervous system—brain cancer	0.0064	0.0152	CbGeAlD
Nandrolone decanoate—CYP19A1—brain—brain cancer	0.00633	0.0151	CbGeAlD
Nandrolone decanoate—MAOA—cerebellum—brain cancer	0.00626	0.0149	CbGeAlD
Nandrolone decanoate—MAOB—brain—brain cancer	0.00596	0.0142	CbGeAlD
Nandrolone decanoate—Urticaria—Procarbazine—brain cancer	0.00572	0.0108	CcSEcCtD
Nandrolone decanoate—AR—brain—brain cancer	0.0056	0.0133	CbGeAlD
Nandrolone decanoate—Oedema—Hydroxyurea—brain cancer	0.00557	0.0105	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Temozolomide—brain cancer	0.00552	0.0104	CcSEcCtD
Nandrolone decanoate—Jaundice—Etoposide—brain cancer	0.00532	0.01	CcSEcCtD
Nandrolone decanoate—Pruritus—Procarbazine—brain cancer	0.00509	0.00961	CcSEcCtD
Nandrolone decanoate—MAOA—brain—brain cancer	0.00508	0.0121	CbGeAlD
Nandrolone decanoate—Hypertension—Carmustine—brain cancer	0.00476	0.00899	CcSEcCtD
Nandrolone decanoate—Hypertension—Temozolomide—brain cancer	0.0046	0.00869	CcSEcCtD
Nandrolone decanoate—Rash—Procarbazine—brain cancer	0.00454	0.00856	CcSEcCtD
Nandrolone decanoate—Dermatitis—Procarbazine—brain cancer	0.00453	0.00856	CcSEcCtD
Nandrolone decanoate—Oedema—Carmustine—brain cancer	0.0045	0.0085	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—brain cancer	0.00442	0.00834	CcSEcCtD
Nandrolone decanoate—Oedema—Temozolomide—brain cancer	0.00435	0.00821	CcSEcCtD
Nandrolone decanoate—Nausea—Procarbazine—brain cancer	0.00427	0.00807	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00403	0.0808	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Etoposide—brain cancer	0.00368	0.00695	CcSEcCtD
Nandrolone decanoate—Rash—Hydroxyurea—brain cancer	0.00351	0.00663	CcSEcCtD
Nandrolone decanoate—Dermatitis—Hydroxyurea—brain cancer	0.00351	0.00662	CcSEcCtD
Nandrolone decanoate—Urticaria—Temozolomide—brain cancer	0.00346	0.00652	CcSEcCtD
Nandrolone decanoate—Nausea—Hydroxyurea—brain cancer	0.00331	0.00624	CcSEcCtD
Nandrolone decanoate—Pruritus—Temozolomide—brain cancer	0.00308	0.00581	CcSEcCtD
Nandrolone decanoate—Rash—Carmustine—brain cancer	0.00284	0.00536	CcSEcCtD
Nandrolone decanoate—Dermatitis—Carmustine—brain cancer	0.00284	0.00535	CcSEcCtD
Nandrolone decanoate—Urticaria—Etoposide—brain cancer	0.00277	0.00522	CcSEcCtD
Nandrolone decanoate—Rash—Temozolomide—brain cancer	0.00274	0.00518	CcSEcCtD
Nandrolone decanoate—Dermatitis—Temozolomide—brain cancer	0.00274	0.00517	CcSEcCtD
Nandrolone decanoate—Nausea—Carmustine—brain cancer	0.00267	0.00505	CcSEcCtD
Nandrolone decanoate—Nausea—Temozolomide—brain cancer	0.00258	0.00488	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—brain cancer	0.00246	0.00465	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00238	0.0478	CbGpPWpGaD
Nandrolone decanoate—Rash—Etoposide—brain cancer	0.0022	0.00414	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—brain cancer	0.00219	0.00414	CcSEcCtD
Nandrolone decanoate—Nausea—Etoposide—brain cancer	0.00207	0.0039	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0018	0.0361	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00177	0.0356	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00176	0.0353	CbGpPWpGaD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SHH—brain cancer	0.00155	0.031	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00149	0.03	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00146	0.0292	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptors—ESR2—brain cancer	0.00139	0.0279	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.00137	0.0276	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP2C9—brain cancer	0.00127	0.0254	CbGpPWpGaD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD2—brain cancer	0.00115	0.0231	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0011	0.0221	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.00106	0.0212	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.00101	0.0202	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HES5—brain cancer	0.000933	0.0187	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000912	0.0183	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000859	0.0172	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000837	0.0168	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP2C9—brain cancer	0.000794	0.0159	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000774	0.0155	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000764	0.0153	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000568	0.0114	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000561	0.0112	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000478	0.00959	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000463	0.00928	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000453	0.00909	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00045	0.00902	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000444	0.0089	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.00044	0.00883	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000399	0.008	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000397	0.00796	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000383	0.00767	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000379	0.0076	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000375	0.00752	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000372	0.00746	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000371	0.00745	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000357	0.00717	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000349	0.00701	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000326	0.00654	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00032	0.00642	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000316	0.00633	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000314	0.0063	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HES1—brain cancer	0.000308	0.00618	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000308	0.00618	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000304	0.0061	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000302	0.00605	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000299	0.006	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000297	0.00596	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000283	0.00567	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000281	0.00564	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000277	0.00556	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000275	0.00551	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00027	0.00541	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000242	0.00486	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000242	0.00485	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.00024	0.00481	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000239	0.0048	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000233	0.00467	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000219	0.0044	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000218	0.00436	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000217	0.00436	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2C9—brain cancer	0.000216	0.00434	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR2—brain cancer	0.00019	0.00381	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BSG—brain cancer	0.000184	0.00369	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000182	0.00364	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.00018	0.00361	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.00018	0.00361	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000175	0.00351	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.00017	0.00342	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000158	0.00318	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—IDH1—brain cancer	0.000158	0.00317	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000156	0.00313	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000155	0.0031	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000155	0.0031	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000154	0.00309	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000151	0.00302	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000149	0.00299	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000146	0.00292	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000143	0.00286	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000136	0.00273	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000136	0.00273	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2C9—brain cancer	0.000136	0.00272	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000132	0.00265	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000131	0.00263	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000125	0.00251	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO2—brain cancer	0.000125	0.00251	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000123	0.00246	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000121	0.00242	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.00012	0.0024	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000118	0.00237	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BSG—brain cancer	0.000115	0.00231	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BSG—brain cancer	0.000113	0.00226	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000103	0.00206	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT1—brain cancer	0.000102	0.00204	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH1—brain cancer	9.93e-05	0.00199	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.91e-05	0.00199	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH1—brain cancer	9.68e-05	0.00194	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR2—brain cancer	9.15e-05	0.00184	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP2C9—brain cancer	8.77e-05	0.514	CrCbGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH2—brain cancer	8.67e-05	0.00174	CbGpPWpGaD
Nandrolone decanoate—Testosterone—CYP2C9—brain cancer	8.29e-05	0.486	CrCbGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.88e-05	0.00158	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO2—brain cancer	7.85e-05	0.00157	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO2—brain cancer	7.65e-05	0.00153	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SIRT1—brain cancer	7.37e-05	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—brain cancer	6e-05	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—brain cancer	5.74e-05	0.00115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—brain cancer	3.6e-05	0.000722	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—brain cancer	3.51e-05	0.000704	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—brain cancer	2.89e-05	0.000579	CbGpPWpGaD
